America ’s biopharmaceutical companies are working around the clock to beat coronavirus

Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization (BIO) underscored the industry ’scommitment to finding solutions to prevent, diagnose and treat those with COVID-19, a disease caused by a novel strain of coronavirus. The decades-long investments biopharmaceutical companies have made in new technologies, research and treatments have prepared the industry to act swiftly to respond to the public health crisis.
Source: The Catalyst - Category: Pharmaceuticals Tags: Research and Development PhRMA Member Company Clinical Trials Infectious Diseases Coronavirus Source Type: news